SERUM INSTITUTE OF INDIA PRIVATE LIMITED PBP I.

Serum Institute of India Private Limited is a factory (manufacturer).

Company Introduction:

Serum Institute of India Private Limited is a premier Indian biotechnology and biopharmaceutical company, headquartered in Pune, India. Established in 1966 by Cyrus S. Poonawalla, it has grown to become the world's largest vaccine manufacturer by dose. The company is dedicated to producing high-quality, affordable vaccines and immunobiologicals for a wide range of diseases, including polio, diphtheria, tetanus, pertussis, Hib, measles, mumps, rubella, and rotavirus. Serum Institute of India plays a critical role in global health by supplying vaccines to over 170 countries, significantly contributing to global immunization efforts and public health initiatives, particularly in low and middle-income nations. Its contributions were notably highlighted during the COVID-19 pandemic through the production of the Covishield vaccine.

The products manufactured or sold by Serum Institute of India Private Limited primarily consist of vaccines. These include:

COVID-19 vaccines (such as Covishield and Covovax)

Polio vaccines (Oral Polio Vaccine and Inactivated Polio Vaccine)

Measles, Mumps, and Rubella (MMR) vaccine

Diphtheria, Tetanus, and Pertussis (DTwP) vaccines

Rotavirus vaccine

Pneumococcal Conjugate Vaccine

Meningococcal vaccines

Rabies vaccine

Human Papillomavirus (HPV) vaccine (Cervavac)

Tetanus Toxoid vaccine

Diphtheria and Tetanus (DT) vaccine

Typhoid Conjugate Vaccine